| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. | Director | Common Stock | 25.3K | $31.4K | $1.24 | Jun 25, 2024 | Direct |
| Kronos Bio, Inc. | Director | Stock Option (Right to Buy) | 17K | Jun 25, 2024 | Direct | ||
| Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16K | Jun 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KRON | Kronos Bio, Inc. | Jun 25, 2024 | 2 | $0 | 4 | Jun 26, 2024 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2023 | 2 | $0 | 4 | Jun 26, 2023 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 29, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4/A | Apr 15, 2022 | Director |
| KYMR | Kymera Therapeutics, Inc. | Mar 12, 2021 | 1 | $0 | 4/A | Apr 15, 2022 | Director |